EMA tells sponsors to incorporate patient experience across product lifecycle
Regulatory NewsJoanne S. Eglovitch
Biologics/ biosimilars/ vaccinesBiotechnologyEuropeEuropean Medicines Agency (EMA)Patient engagementPatient reported outcomesPatient voicePatient-focused drug developmentPharmaceuticalsProduct developmentProduct LifecycleRegulatory harmonizationRegulatory Intelligence/Policy